Xilio Therapeutics Inc (XLO)
1.16
+0.08
(+7.41%)
USD |
NASDAQ |
May 17, 13:21
Xilio Therapeutics Price to Book Value: 1.662 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.547 |
| May 15, 2024 | 1.605 |
| May 14, 2024 | 1.562 |
| May 13, 2024 | 1.605 |
| May 10, 2024 | 1.690 |
| May 09, 2024 | 1.805 |
| May 08, 2024 | 1.734 |
| May 07, 2024 | 1.805 |
| May 06, 2024 | 1.791 |
| May 03, 2024 | 1.690 |
| May 02, 2024 | 1.504 |
| May 01, 2024 | 1.547 |
| April 30, 2024 | 1.49 |
| April 29, 2024 | 1.49 |
| April 26, 2024 | 1.562 |
| April 25, 2024 | 1.447 |
| April 24, 2024 | 1.519 |
| April 23, 2024 | 1.504 |
| April 22, 2024 | 1.576 |
| April 19, 2024 | 1.648 |
| April 18, 2024 | 1.834 |
| April 17, 2024 | 1.762 |
| April 16, 2024 | 1.862 |
| April 15, 2024 | 1.805 |
| April 12, 2024 | 1.690 |
| Date | Value |
|---|---|
| April 11, 2024 | 1.820 |
| April 10, 2024 | 1.713 |
| April 09, 2024 | 1.753 |
| April 08, 2024 | 1.967 |
| April 05, 2024 | 1.606 |
| April 04, 2024 | 1.619 |
| April 03, 2024 | 1.739 |
| April 02, 2024 | 1.980 |
| April 01, 2024 | 2.047 |
| March 28, 2024 | 1.011 |
| March 27, 2024 | 0.4791 |
| March 26, 2024 | 0.4944 |
| March 25, 2024 | 0.5248 |
| March 22, 2024 | 0.5304 |
| March 21, 2024 | 0.5266 |
| March 20, 2024 | 0.518 |
| March 19, 2024 | 0.5135 |
| March 18, 2024 | 0.5088 |
| March 15, 2024 | 0.5135 |
| March 14, 2024 | 0.4847 |
| March 13, 2024 | 0.5248 |
| March 12, 2024 | 0.5026 |
| March 11, 2024 | 0.5673 |
| March 08, 2024 | 0.6222 |
| March 07, 2024 | 0.599 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2625
Minimum
Dec 20 2023
2.368
Maximum
Jan 03 2022
0.8855
Average
0.7697
Median
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.808 |
| FibroGen Inc | -- |
| Avalo Therapeutics Inc | 1.303 |
| IGM Biosciences Inc | 3.426 |
| AEON Biopharma Inc | -- |
Price to Book Value Related Metrics
| Price | 1.16 |
| Earnings Yield | -221.6% |
| Market Cap | 42.82M |